---
title: "Incadronic Acid - Osteoporosis"
sidebar: mydoc_sidebar
permalink: db06255-mesh-d010024-1.html
toc: false 
---


Path ID: `DB06255_MESH_D010024_1`
{% include image.html url="images/db06255-mesh-d010024-1.png" file="db06255-mesh-d010024-1.png" alt="db06255-mesh-d010024-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C071542">MESH:C071542 </a> | incadronic acid | Drug |
| <a href="https://identifiers.org/UniProt:P14324">UniProt:P14324 </a> | Farnesyl pyrophosphate synthase | Protein |
| <a href="https://identifiers.org/GO:0008299">GO:0008299 </a> | isoprenoid biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0045453">GO:0045453 </a> | bone resorption | BiologicalProcess |
| <a href="https://identifiers.org/HP:0004349">HP:0004349 </a> | Reduced bone mineral density | PhenotypicFeature |
| <a href="https://identifiers.org/CHEBI:52255">CHEBI:52255 </a> | hydroxylapatite | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0006915">GO:0006915 </a> | apoptotic process | BiologicalProcess |
| <a href="https://identifiers.org/CL:0000092">CL:0000092 </a> | osteoclast | Cell |
| <a href="https://identifiers.org/GO:0001503">GO:0001503 </a> | ossification | BiologicalProcess |
| <a href="https://identifiers.org/GO:1990523">GO:1990523 </a> | bone regeneration | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D010024">MESH:D010024 </a> | Osteoporosis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Incadronic Acid | DECREASES ACTIVITY OF | Farnesyl Pyrophosphate Synthase |
| Farnesyl Pyrophosphate Synthase | POSITIVELY REGULATES | Isoprenoid Biosynthetic Process |
| Isoprenoid Biosynthetic Process | POSITIVELY CORRELATED WITH | Bone Resorption |
| Bone Resorption | POSITIVELY CORRELATED WITH | Reduced Bone Mineral Density |
| Reduced Bone Mineral Density | MANIFESTATION OF | Osteoporosis |
| Incadronic Acid | POSITIVELY REGULATES | Apoptotic Process |
| Apoptotic Process | DECREASES ABUNDANCE OF | Osteoclast |
| Osteoclast | POSITIVELY REGULATES | Bone Resorption |
| Incadronic Acid | MOLECULARLY INTERACTS WITH | Hydroxylapatite |
| Hydroxylapatite | POSITIVELY CORRELATED WITH | Ossification |
| Hydroxylapatite | POSITIVELY CORRELATED WITH | Bone Regeneration |
| Bone Regeneration | NEGATIVELY CORRELATED WITH | Osteoporosis |
| Ossification | NEGATIVELY CORRELATED WITH | Osteoporosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06255](https://go.drugbank.com/drugs/DB06255)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/3699#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/3699#section=Mechanism-of-Action)
  - [https://en.wikipedia.org/wiki/Bisphosphonate](https://en.wikipedia.org/wiki/Bisphosphonate)
